Exchange Announces Preliminary Designation of Jeonjin Bio Pharm as a Non-Compliant Disclosure Corporation Due to Disclosure Failures...
The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
Hot Picks Today
!["Sold Already? That Must Sting"... Gold Surges 15% in a Month, U.S. Treasuries Behind the Rally [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2026082718281195698_1787822890.png)
"Sold Already? That Must Sting"... Gold Surges 15% in a Month, U.S. Treasuries Behind the Rally [Weekend Money]
- "We Can't Live With So Many Tourists"... Japan to Impose Nightly Accommodation Tax as Visitor Numbers Soar
- "Excited for 400,000 Won" Turns to Anger: "It Feels Like an Insult" as Basic Pension Leaves Seniors with No Income Gain
- "Quietly Among Ourselves"... 14,000 Unmanned Mahjong Parlors Open in 3 Years as Millennials and Gen Z Flock in China
- "Who Would Visit Now?" Foot Traffic Plummets... Japan Appeals to Koreans for Help—Here's Why
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
